Prostate Cancer Research has announced that former UK prime minister Rishi Sunak has joined the charity as an ambassador.

The University of Manchester, UK, has announced the launch of its British Heart Foundation (BHF) Manchester Centre of Research Excellence following a £4m backing from the heart and circulatory research charity.

communique.awardsplatform.com

PharmaRole.com

Welcome to the March issue of Pharmafocus! As the country enjoys warmer temperatures and sunnier skies at the beginning of spring, this time of year is always a time of growth and renewal and the pharma industry is no different.

EDX Medical – a clinical diagnostics company founded by Sir Christopher Evans, OBE – has announced the development of a new ‘super test’ for prostate cancer.

Global pharma company Thermo Fisher Scientific has announced the launch of CorEvitas Adolescent Alopecia Registry, which aims to address an unmet need in the research for adolescent alopecia.

To mark last month’s World Cancer Day, a new plan was unveiled by the UK Government to help tackle the impact of cancer across England.

flypharmaeurope.com

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be used to fund a phase 1 study into its dry age-related macular degeneration (AMD) therapy, PST-611. The funding round was supported by existing investor Pureos BioVentures.

Paragon Bioscience’s clinical biopharma spin-out, Emalex Bioscience, has announced that its lead candidate for the treatment of Tourette syndrome has met its primary and secondary endpoints in a recent phase 3 study.

Recce Pharmaceuticals has announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment of acute bacterial skin and skin structure infections (ABSSSIs), including diabetic foot infections (DFI).